Moderna's mRNA patent invalidated by European Patent Office in vaccine dispute with BioNTech
The European Patent Office has declared a contested mRNA patent owned by Moderna invalid, giving a victory to BioNTech and Pfizer in their patent dispute. Moderna plans to appeal the decision, while BioNTech welcomes the ruling, stating that Moderna's patents do not meet the requirements for grant. Moderna has previously sued BioNTech in multiple countries, alleging the copying of its mRNA technology.